Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yerly

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|February 1, 1995
Response of HIV RNA to didanosine as a predictive marker of survivalS Yerly, L Kaiser, B Mermillod, et al.
Lancet (London, England)|December 24, 1994
Mother to child transmission of zidovudine-resistant HIV-1C A Siegrist, S Yerly, L Kaiser, et al.
AIDS (London, England)|November 1, 1993
High levels of circulating RNA in patients with symptomatic HIV-1 infectionC Baumberger, S Kinloch-de-Loës, S Yerly, et al.
The Journal of Infectious Diseases|August 7, 1999
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort StudyS Yerly, O T Rutschmann, M Opravil, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Impact of PUVA therapy on HIV viremia: a pilot studyM Pechère, S Yerly, E Lemonnier, et al.
Antiviral Therapy|January 1, 1997
Zidovudine plus didanosine in primary HIV-1 infectionL Perrin, S Yerly, A Charvier, et al.
Lancet (London, England)|September 4, 1999
Transmission of antiretroviral-drug-resistant HIV-1 variantsS Yerly, L Kaiser, E Race, et al.
The Journal of Infectious Diseases|February 10, 1999
Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' StudyC Kully, S Yerly, P Erb, et al.
AIDS (London, England)|September 8, 2001
Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patientsA Oxenius, S Yerly, E Ramirez, et al.
The Journal of Infectious Diseases|June 1, 1996
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study GroupA Galetto-Lacour, S Yerly, T V Perneger, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|February 1, 1995
Response of HIV RNA to didanosine as a predictive marker of survivalS Yerly, L Kaiser, B Mermillod, et al.
Lancet (London, England)|December 24, 1994
Mother to child transmission of zidovudine-resistant HIV-1C A Siegrist, S Yerly, L Kaiser, et al.
AIDS (London, England)|November 1, 1993
High levels of circulating RNA in patients with symptomatic HIV-1 infectionC Baumberger, S Kinloch-de-Loës, S Yerly, et al.
The Journal of Infectious Diseases|August 7, 1999
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort StudyS Yerly, O T Rutschmann, M Opravil, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Impact of PUVA therapy on HIV viremia: a pilot studyM Pechère, S Yerly, E Lemonnier, et al.
Antiviral Therapy|January 1, 1997
Zidovudine plus didanosine in primary HIV-1 infectionL Perrin, S Yerly, A Charvier, et al.
Lancet (London, England)|September 4, 1999
Transmission of antiretroviral-drug-resistant HIV-1 variantsS Yerly, L Kaiser, E Race, et al.
The Journal of Infectious Diseases|February 10, 1999
Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' StudyC Kully, S Yerly, P Erb, et al.
AIDS (London, England)|September 8, 2001
Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patientsA Oxenius, S Yerly, E Ramirez, et al.
The Journal of Infectious Diseases|June 1, 1996
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study GroupA Galetto-Lacour, S Yerly, T V Perneger, et al.
Pageof 9